BANK VONTOBEL AG | Market Closed - Swiss Exchange 11:20:00 2024-06-11 am EDT | ||
| 100.5 USD | +0.10% |
|
| Current month | +0.50% | ||
| 1 month | +0.30% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-11 | 100.5 | +0.10% |
| 24-06-06 | 100.4 | +0.10% |
| 24-06-05 | 100.3 | +0.10% |
Delayed Quote Swiss Exchange
Last update June 11, 2024 at 11:20 am EDT
More quotesStatic data
| Product type | Reverse Convertibles |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| RBIADV | |
| ISIN | CH1333291909 |
| Date issued | 2024-04-17 |
| Strike | 194.4 $ |
| Maturity | 2025-04-17 (308 Days) |
| Parity | 0.19 : 1 |
| Emission price | 98 $ |
| Emission volume | N/A |
| Settlement | both |
| Currency | USD |
Technical Indicators
| Highest since issue | 100.5 $ |
|---|---|
| Lowest since issue | 97.9 $ |
| Spread | 5 $ |
| Spread % | 0.50% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
233.8
USD
Average target price
284.6
USD
Spread / Average Target
+21.73%
- Stock Market
- Certificates
- RBIADV Certificat
